ImmuDyne’s Motion in Biothera Patent Infringement Lawsuit Denied
EAGAN, MN – May 29, 2008 – A Minnesota Federal District Court has rejected ImmuDyne Inc.’s motion to dismiss Biothera’s request for a permanent injunction. Biothera is suing ImmuDyne for patent infringement.
The lawsuit alleges that ImmuDyne has violated U.S. Patent Nos. 4,992,540, 5,037,972, 4,962,094 and 6,020,3424, which provide Biothera with ownership and exclusive rights to manufacture and sell yeast-derived immune health dietary supplements and ingredients.
Biothera is satisfied with the court’s decision and remains confident in a successful outcome.
About Biothera, the Immune Health Company
Biothera is a biotechnology company dedicated to improving immune health. The company is developing pharmaceuticals that engage the innate immune system to fight cancer. Biothera also manufactures and markets Wellmune WGP and other food-grade ingredients that support healthy immune function to the functional food and beverage, nutritional supplement, cosmetic and animal nutrition markets.
Contact:
David Walsh
VP Communications
Biothera, the Immune Health Company
651-256-4606